DK0598365T3 - - Google Patents
Info
- Publication number
- DK0598365T3 DK0598365T3 DK93118411.3T DK93118411T DK0598365T3 DK 0598365 T3 DK0598365 T3 DK 0598365T3 DK 93118411 T DK93118411 T DK 93118411T DK 0598365 T3 DK0598365 T3 DK 0598365T3
- Authority
- DK
- Denmark
- Prior art keywords
- weight
- gamma
- agent
- treatment
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
Abstract
Agent for the treatment of atopic eczema and other inflammatory skin diseases consisting of a composition for external use containing at least 0.5% by weight of gamma-linolenic acid and/or eicosapentaenoic acid and in addition 1 to 30% by weight of water-soluble magnesium salts.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4238869A DE4238869C2 (en) | 1992-11-18 | 1992-11-18 | Agents for the treatment of atopic eczema and other inflammatory skin diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0598365T3 true DK0598365T3 (en) | 1997-02-24 |
Family
ID=6473154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93118411.3T DK0598365T3 (en) | 1992-11-18 | 1993-11-13 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0598365B1 (en) |
AT (1) | ATE142491T1 (en) |
DE (2) | DE4238869C2 (en) |
DK (1) | DK0598365T3 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19611953A1 (en) * | 1996-03-26 | 1997-10-02 | Beiersdorf Ag | Use of unsaturated monocarboxylic acids against superinfections |
FR2765482B1 (en) * | 1997-07-07 | 2000-12-08 | Oreal | USE OF Y-LINOLENIC ACID TO PREVENT OXIDATIVE STRESS |
US7138431B1 (en) | 1998-02-23 | 2006-11-21 | Wake Forest University | Dietary control of arachidonic acid metabolism |
US6107334A (en) * | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
DE10347824B4 (en) * | 2003-10-10 | 2011-08-11 | Lach, Hans-Joachim, Dr., 79331 | Pharmaceutical or cosmetic composition for the treatment of the skin |
GB0517043D0 (en) * | 2005-08-19 | 2005-09-28 | York Pharma Plc | Improvements in pharmaceutical compositions |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
US8673325B1 (en) * | 2012-09-06 | 2014-03-18 | Dignity Sciences Limited | Cosmetic compositions comprising EPA and salicylic acid and methods of making and using same |
RU2020101477A (en) | 2014-06-04 | 2020-06-19 | Дигнити Сайенсиз Лимитед | PHARMACEUTICAL COMPOSITIONS CONTAINING DGLK AND THEIR APPLICATION |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2548021B1 (en) * | 1983-06-29 | 1986-02-28 | Dick P R | PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS |
US4885157A (en) * | 1987-02-13 | 1989-12-05 | Fiaschetti Mary G | Dermal cosmetic composition and applications therefor |
EP0432700A3 (en) * | 1987-08-25 | 1991-06-26 | Efamol Holdings Plc | Use of lithium compounds for the treatment of combination skin |
EP0561766B1 (en) * | 1988-01-14 | 1995-11-02 | FRITHZ, Anders | Use of essential fatty acids for the preparation of a drug for the treatment of eczema |
DK0391218T3 (en) * | 1989-04-04 | 1996-07-29 | Beiersdorf Ag | Means for the prevention of atopy |
DE59002748D1 (en) * | 1990-01-29 | 1993-10-21 | Wogepharm Gmbh | Process for the preparation of agents for the therapy of skin diseases. |
DE4042437A1 (en) * | 1990-07-18 | 1992-06-11 | Braun Melsungen Ag | Topical compsn. for treating burns - contg. omega-3-fatty acid esp. eicosa-penta:enoic acid as fish oil component, providing rapid healing |
-
1992
- 1992-11-18 DE DE4238869A patent/DE4238869C2/en not_active Expired - Fee Related
-
1993
- 1993-11-13 EP EP93118411A patent/EP0598365B1/en not_active Expired - Lifetime
- 1993-11-13 DK DK93118411.3T patent/DK0598365T3/da active
- 1993-11-13 DE DE59303744T patent/DE59303744D1/en not_active Expired - Fee Related
- 1993-11-13 AT AT93118411T patent/ATE142491T1/en active
Also Published As
Publication number | Publication date |
---|---|
ATE142491T1 (en) | 1996-09-15 |
DE59303744D1 (en) | 1996-10-17 |
EP0598365A1 (en) | 1994-05-25 |
EP0598365B1 (en) | 1996-09-11 |
DE4238869A1 (en) | 1994-05-19 |
DE4238869C2 (en) | 1994-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2221843B (en) | Fatty acid composition | |
IL93351A (en) | Methods and compositions for preserving food products using conjugated linoleic acids and some new salts of conjugated linoleic acids for use therein | |
HK37694A (en) | Fatty acids compositions | |
ZA935976B (en) | Fatty acid treatment. | |
EP0222483A3 (en) | Use of gamma-linolenic acid and related compounds in the treatment of endometriosis | |
IN166787B (en) | ||
DK0598365T3 (en) | ||
ZA884484B (en) | Essential fatty acid compositions | |
ATE258792T1 (en) | HIGH LIPID DIET | |
SG81882A1 (en) | Retinoid composition | |
LV10046A (en) | Preparation for vascular damage prevention and treatment and use of pyridoxal glutaminate 5'-phosphate magnesium salt for vascular damage prevention and treatment | |
AU669946B2 (en) | Lanolin/lanolin acid ester skin treatment composition | |
GR3026708T3 (en) | Use of fatty acids for treating abnormal tissue calcification. | |
TW223589B (en) | ||
GB2208798B (en) | Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative | |
RO100495A2 (en) | 10 percent solution ascorbic acid magnesium salt preparation process | |
CA2073673A1 (en) | Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors |